BioHarvest Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	23.03	2.39	5.36	1.74	4.12
Cash & Short-Term Investments	23.03	2.39	5.36	1.74	4.12
Cash Growth	863.39%	-55.37%	208.47%	-57.83%	130.90%
Accounts Receivable	2.92	1.81	1.23	1.21	0.62
Inventory	4.56	3.66	2.47	1.38	0.93
Total Current Assets	30.5	7.86	9.05	4.32	5.67
Net Property, Plant & Equipment	16.73	16.77	5.77	4.91	4.36
Other Long-Term Assets	0.43	0.37	0.18	0.16	0.18
Total Assets	47.67	25	15	9.39	10.21
Accounts Payable	4.8	7.13	3.85	2.81	2.15
Accrued Expenses	0.39	0.4	0.46	0.16	0.14
Short-Term Debt	0.15	3.91	-	-	-
Current Portion of Long-Term Debt	-	-	20.53	8.55	-
Current Portion of Leases	1.41	0.77	0.38	-	-
Unearned Revenue	0.49	0.91	0.72	-	-
Other Current Liabilities	0.45	1.14	0.53	-	0.64
Total Current Liabilities	7.68	14.26	26.47	11.52	2.92
Long-Term Debt	2.42	-	-	-	-
Long-Term Leases	10.13	9.14	1.43	1.67	2.27
Other Long-Term Liabilities	1.98	0.27	1.96	2.13	2.16
Total Long-Term Liabilities	14.53	9.41	3.39	3.8	4.43
Total Liabilities	22.22	23.67	29.86	15.32	7.35
Common Stock	133	97.75	68.65	65.01	62.56
Retained Earnings	-107.55	-96.42	-83.51	-70.94	-59.71
Shareholders' Equity	25.45	1.33	-14.85	-5.93	2.86
Total Liabilities & Equity	47.67	25	15	9.39	10.21
Total Debt	14.1	13.82	22.34	10.22	2.27
Net Cash (Debt)	8.92	-11.43	-16.99	-8.48	1.84
Net Cash Per Share	0.48	-0.71	-1.25	-0.65	0.15
Book Value	25.45	1.33	-14.85	-5.93	2.86
Book Value Per Share	1.38	0.08	-1.10	-0.45	0.23
Tangible Book Value	25.45	1.33	-14.85	-5.93	2.86
Tangible Book Value Per Share	1.38	0.08	-1.10	-0.45	0.23

Updated Apr 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q